Conference Coverage
Conference Coverage
First Long-Term Data on Atogepant for Migraine Prevention
“This is the first long-term study for assessing the safety and efficacy of a drug belonging to the gepant class.”
Conference Coverage
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
The results underscore the need for psychiatric evaluations in patients with a headache disorder.
Conference Coverage
‘Compelling’ Results for AI EEG to Predict Functional Outcomes
“Our study addresses the critical need for automation in monitoring epileptic activity and seizure burden.”
Conference Coverage
In Lecanemab Alzheimer Extension Study, Placebo Roll-Over Group Does Not Catch Up
New data show little late benefit, but lecanemab is active when tau is low.
Conference Coverage
One-Minute Speech Test Could Help Assess Dementia Risk
A brief speech test that is not culture or education dependent may aid in dementia screening.
Latest News
Positive Results for Intranasal Oxytocin in Adults With Autism
Those receiving intranasal oxytocin showed clinical improvement on multiple mental health and quality of life measures.
Conference Coverage
Prominent Researcher Describes Pivot From ALS Treatment to Prevention
After a long career that has included participation in a series of promising but failed treatment trials for ALS, a prominent researcher has...
Conference Coverage
Antidiabetic Drugs That Lower Stroke Risk Do So By Unclear Mechanisms
Some newer antidiabetic therapies provide protection against stroke even though their glycemic control is no better than the agents that have no...
Conference Coverage
Environmental Chemicals Linked to Parkinson’s Disease in Urban Areas
A large, nationwide study is the first to show an association between TCE and Parkinson’s in the general population.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Conference Coverage
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive Cancers
New study results suggest ctDNA dynamics provide an early window into predicting response to targeted therapies in patients with HER2-altered...